Introduction: Since diabetes is characterized by impaired ability of pancreatic betacells to respond and/or produce insulin, new approaches for renewal and replacement of deficient beta-cells are indispensable. The aim of this study is direct pancreatic alpha- to beta-cells transdifferentiation by using a new synthetic epigenetic tool, Epi-CRISPR system. Using Epi-CRISPR system we aim to introduce targeted DNA methylation and subsequent repression of genes responsible for maintaining alpha-cell identity. Methods: AlphaTC1-6 cells (α-cells) were transiently transfected with dCas9-Dnmt3a- Dnmt3L constructs and one or four different vectors containing guide RNA components for specific targeting the promoter region of aristaless-related homeobo...
© 2015 Macmillan Publishers Limited. Type 1 diabetes results from the autoimmune destruction of the ...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
Both type 1 and type 2 diabetes are conditions that are associated with the loss of insulin-producin...
Since diabetes is characterized by impaired ability of pancreatic beta-cells to respond and/or produ...
Since diabetes is characterized by impaired ability of pancreatic beta-cells to respond and/or produ...
Introduction: Beta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presen...
Introduction: Beta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presen...
Introduction: Beta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presen...
The raising worldwide prevalence of Type 1 and Type 2 diabetes mellitus (T1DM and T2DM) solicits the...
Diabetes mellitus (DM) is a severe and frequent disease with increasing prevalence. It is not possib...
Background and aims: The CXC chemokine ligand 12 (CXCL12/SDF-1) promotes the expressi...
Background and aims: The CXC chemokine ligand 12 (CXCL12/SDF-1) promotes the expressi...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
Type 1 diabetes results from the autoimmune destruction of the insulin-producing pancreatic beta (β)...
© 2015 Macmillan Publishers Limited. Type 1 diabetes results from the autoimmune destruction of the ...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
Both type 1 and type 2 diabetes are conditions that are associated with the loss of insulin-producin...
Since diabetes is characterized by impaired ability of pancreatic beta-cells to respond and/or produ...
Since diabetes is characterized by impaired ability of pancreatic beta-cells to respond and/or produ...
Introduction: Beta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presen...
Introduction: Beta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presen...
Introduction: Beta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presen...
The raising worldwide prevalence of Type 1 and Type 2 diabetes mellitus (T1DM and T2DM) solicits the...
Diabetes mellitus (DM) is a severe and frequent disease with increasing prevalence. It is not possib...
Background and aims: The CXC chemokine ligand 12 (CXCL12/SDF-1) promotes the expressi...
Background and aims: The CXC chemokine ligand 12 (CXCL12/SDF-1) promotes the expressi...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
Type 1 diabetes results from the autoimmune destruction of the insulin-producing pancreatic beta (β)...
© 2015 Macmillan Publishers Limited. Type 1 diabetes results from the autoimmune destruction of the ...
β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated ...
Both type 1 and type 2 diabetes are conditions that are associated with the loss of insulin-producin...